Carbapenem-Based Antibiotics Market Forecast to 2028

Report Code : TIPRE00027228 | Region : Global | Industry : Pharmaceuticals | Published Date : 23/Feb/2022
Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)

The carbapenem-based antibiotics market size is projected to reach US$ 5,346.62 million by 2028 from US$ 3,964.57 million in 2021; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.

Generic versions of antibiotics are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. The focus of generic drug producers is to increase the reach of these drugs. Moreover, the shortage of antibiotics to treat bacterial infections is also one of the prime factors driving the market’s growth. The increased production of generic carbapenem-based antibiotics has enlarged the drug availability in various low- and middle-income countries.

Generic versions of carbapenem drugs available in the market are ertapenem (Invanz), imipenem/cilastatin (Primaxin IM), doripenem (Doribax), and meropenem (Merrem). In addition, the growing number of generic players in the market is accelerating the production of generic drugs. Many Asian companies are engaged in developing active pharmaceutical ingredients (API), which are required to produce generic carbapenem-based antibiotics. In June 2021, JW Pharmaceutical, a South Korean company, announced it had completed production of its API for Ertapenem injection and shipped it to the US. The company plans to enter the global carbapenem antibiotic market in the coming years. It has also succeeded in developing its technology independently in Korea to produce Doripenem. Furthermore, the company plans to expand the sales of both API and finished drugs of Imipenem and Meropenem by exporting them to over 40 countries, including China and Japan. As a result, companies are accelerating generic drug production and driving the growth of the global carbapenem-based antibiotics market.

Based on type, the carbapenem-based antibiotics market is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest market share of the carbapenem based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the carbapenem-based antibiotics market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.

Based on indication, the carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021 and is estimated to register the highest CAGR in the market during the forecast period.

By distribution channel, the carbapenem-based antibiotics market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period.

Based on geography, the carbapenem-based antibiotics market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. North America dominates the global market share and is expected to hold its strong foothold in the coming years. The region is expected to witness a consistent growth in the future owing to factors such as increased adoption of carbapenem based antibiotics, high prescription rate of antibiotics, and advancements in research and development leading to the emergence and launch of new medicines. However, the market in Asia Pacific is expected to witness the fastest growth in the coming years. The carbapenem-based antibiotics market size in India and China is expected to grow rapidly owing to factors such as the large population, increasing focus of market players on developing novel vaccines and products at affordable prices, and high penetration of market players manufacturing generic drugs and exporting them across the world.

The World Health Organization (WHO), Food and Drug Administration (FDA), Saudi Clinical Trial Registry, National Institute for Health, Ministry of Health and Prevention, and Centers for Disease Control and Prevention (CDC) are among the primary and secondary sources referred to while preparing the report on the global carbapenem-based antibiotics market.

The List of Companies - Carbapenem Based Antibiotics Market

1. Pfizer Inc.

2. Savior Lifetec

3. Sumitomo Dainippon Pharma Co., Ltd.

4. Merck & Co., Inc.

5. Gland Pharma Limited

6. Aurobindo Pharma Ltd

7. Daewoong Pharmaceutical Co.,Ltd,

8. Iterum Therapeutics plc

9. ACS Dobfar S.p.A

10. Spero Therapeutics

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Carbapenem-based Antibiotics Market – By Type

1.3.2 Global Carbapenem-based Antibiotics Market – By Indication

1.3.3 Global Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4 Global Carbapenem-based Antibiotics Market – By Geography

2. Carbapenem-based Antibiotics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Carbapenem-based Antibiotics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America– PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific– PEST Analysis

4.2.4 Middle East and Africa– PEST Analysis

4.2.5 South and Central America– PEST Analysis

4.3 Expert Opinions

5. Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1 Drivers

5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2 Increasing Production of Generic Drugs

5.2 Market Restraints

5.2.1 Tedious and Expensive Process of Antibiotic Development

5.3 Market Opportunities

5.3.1 Private and Public Partnerships

5.4 Future Trends

5.4.1 Strategic Advancement for New Antibiotic Identification

5.5 Impact Analysis

6. Carbapenem-based Antibiotics Market – Global Analysis

6.1 Global Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

6.2 Global Carbapenem-based Antibiotics Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Carbapenem-based Antibiotics Market Analysis – By Type

7.1 Overview

7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

7.3 Meropenem

7.3.1 Overview

7.3.2 Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Doripenem

7.4.1 Overview

7.4.2 Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Imipenem

7.5.1 Overview

7.5.2 Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Tebipenem

7.6.1 Overview

7.6.2 Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8. Carbapenem-based Antibiotics Market – By Indication

8.1 Overview

8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

8.3 Bacterial Meningitis

8.3.1 Overview

8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Acute Pelvic Infections

8.4.1 Overview

8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Respiratory Tract Infections

8.5.1 Overview

8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Intra-abdominal Infections

8.6.1 Overview

8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9. Carbapenem-based Antibiotics Market – By Distribution Channel

9.1 Overview

9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

9.3 Retail Pharmacies

9.3.1 Overview

9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Online Pharmacies

9.4.1 Overview

9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hospital Pharmacies

9.5.1 Overview

9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10. Carbapenem-based Antibiotics Market – Regional Analysis

10.1 North America: Carbapenem-based Antibiotics Market

10.1.1 Overview

10.1.2 North America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3 North America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4 North America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.1.5 North America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.6 North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1 US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.2 US: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.3 US: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.1.4 US: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.2 Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1 Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.2 Canada: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.3 Canada: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.2.4 Canada: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.3 Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1 Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.2 Mexico: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.3 Mexico: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.3.4 Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.2 Europe: Carbapenem-based Antibiotics Market

10.2.1 Overview

10.2.2 Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.3 Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.4 Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.2.5 Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.2.6 Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.2.6.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.1.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.1.2 UK: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.6.1.3 UK: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.2.6.1.4 UK: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.2.6.2 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.2.1 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.2.2 Germany: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.6.2.3 Germany: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.2.6.2.4 Germany: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.2.6.3 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.3.1 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.3.2 France: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.6.3.3 France: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.2.6.3.4 France: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.2.6.4 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.4.1 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.4.2 Italy: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.6.4.3 Italy: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.2.6.4.4 Italy: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.2.6.5 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.5.1 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.5.2 Spain: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.6.5.3 Spain: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.2.6.5.4 Spain: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.2.6.6 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.6.1 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.2.6.6.2 Rest of Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.2.6.6.3 Rest of Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.2.6.6.4 Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.3 Asia Pacific: Carbapenem-based Antibiotics Market

10.3.1 Overview

10.3.2 Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.3 Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.4 Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.3.5 Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.3.6 Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.1.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.1.2 China: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.6.1.3 China: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.3.6.1.4 China: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.3.6.2 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.2.1 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.2.2 Japan: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.6.2.3 Japan: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.3.6.2.4 Japan: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.3.6.3 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.3.1 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.3.2 India: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.6.3.3 India: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.3.6.3.4 India: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.3.6.4 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.4.1 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.4.2 Australia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.6.4.3 Australia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.3.6.4.4 Australia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.3.6.5 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.5.1 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.5.2 South Korea: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.6.5.3 South Korea: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.3.6.5.4 South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.3.6.6 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.6.1 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.3.6.6.2 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.3.6.6.3 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.3.6.6.4 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.4 Middle East and Africa: Carbapenem-based Antibiotics Market

10.4.1 Overview

10.4.2 Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.3 Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.4.4 Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.4.5 Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.4.6 Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.4.6.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.1.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.1.2 UAE: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.1.3 UAE: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.4.6.1.4 UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.4.6.2 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.2.1 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.2.2 Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.2.3 Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.4.6.2.4 Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.4.6.3 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.3.1 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.3.2 South Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.3.3 South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.4.6.3.4 South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.4.6.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.4.1 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.4.6.4.2 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.4.6.4.3 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.4.6.4.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.5 South and Central America: Carbapenem-based Antibiotics Market

10.5.1 Overview

10.5.2 South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.3 South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.5.4 South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.5.5 South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.5.6 South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.6.1.1 Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.6.1.2 Brazil: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.5.6.1.3 Brazil: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.5.6.1.4 Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.5.6.2 Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.6.2.1 Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.6.2.2 Argentina: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.5.6.2.3 Argentina: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.5.6.2.4 Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.5.6.3 Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.6.3.1 Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.5.6.3.2 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.5.6.3.3 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.5.6.3.4 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

11. Impact of COVID-19 Pandemic on Global Carbapenem-based Antibiotics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Carbapenem-based Antibiotics Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Carbapenem-based Antibiotics Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. COMPANY PROFILES

13.1 ACS Dobfar S.p.A

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Iterum Therapeutics plc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 DAEWOONG PHARMACEUTICAL CO.,LTD

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Aurobindo Pharma Ltd

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Gland Pharma Limited

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Merck & Co., Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Sumitomo Dainippon Pharma Co., Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Savior Lifetec

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Pfizer Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Spero Therapeutics

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. North America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. US: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. US: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. US: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Canada: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Canada: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Canada: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. Mexico: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. Mexico: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14. Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 15. Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 17. UK: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 18. UK: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 19. Germany: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 20. Germany: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 21. Germany: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 22. France: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 23. France: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 24. France: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 25. Italy: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 26. Italy: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 27. Italy: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 28. Spain: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 29. Spain: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 30. Spain: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 31. Rest of Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 32. Rest of Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 33. Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 34. Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 35. Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 36. Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 37. China: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 38. China: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 39. China: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 40. Japan: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 41. Japan: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 42. Japan: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 43. India: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 44. India: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 45. India: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 46. Australia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 47. Australia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 48. Australia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 49. South Korea: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 50. South Korea: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 51. South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 52. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 53. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 54. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 55. Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 56. Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 57. Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 58. UAE: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 59. UAE: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 60. UAE: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 61. Saudi Arabia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 62. Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 63. Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 64. South Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 65. South Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 66. South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 67. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 68. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 69. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 70. South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 71. South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 72. South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 73. Brazil: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 74. Brazil: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 75. Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 76. Argentina: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 77. Argentina: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 78. Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 79. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 80. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 81. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 82. Organic Developments in the Carbapenem-based Antibiotics Market

Table 83. Inorganic Developments in the Carbapenem-based Antibiotics Market

Table 84. Glossary of Terms, Carbapenem-based Antibiotics Market

The List of Companies - Carbapenem Based Antibiotics Market

1. Pfizer Inc.

2. Savior Lifetec

3. Sumitomo Dainippon Pharma Co., Ltd.

4. Merck & Co., Inc.

5. Gland Pharma Limited

6. Aurobindo Pharma Ltd

7. Daewoong Pharmaceutical Co.,Ltd,

8. Iterum Therapeutics plc

9. ACS Dobfar S.p.A

10. Spero Therapeutics

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global carbapenem based antibiotics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global carbapenem based antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Carbapenem-Based Antibiotics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry